NCT03275402 2024-02-13131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal MetastasesY-mAbs TherapeuticsPhase 2/3 Terminated52 enrolled 11 charts
NCT00539500 2019-07-26Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk NeuroblastomaM.D. Anderson Cancer CenterPhase 2/3 Terminated3 enrolled 4 charts